Skip to main content
In stock | Cellular Therapy

Remestemcel-L

Oncology Type Hematologic
Drug Class / Mechanism Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Therapy
No Image
Description

Remestemcel-L is classified as an Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Therapy, sourced for use within our Cellular Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Cellular Therapy
Oncology Type Hematologic

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3